HLA-DQ in Acute Kidney Transplantation Rejection
Impact of HLA-DQ Mismatch on Acute Rejection of Kidney Transplantation
1 other identifier
observational
30
1 country
1
Brief Summary
\- Study the impact of HLA-DQ mismatch on acute rejection of Kidney transplantation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2019
CompletedFirst Posted
Study publicly available on registry
April 1, 2019
CompletedStudy Start
First participant enrolled
May 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2020
CompletedMay 19, 2020
May 1, 2020
1 year
March 26, 2019
May 17, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Combined incidence of DSA or IA on peripheral blood molecular profiling
DSA considered as a binary variable (positive or negative), with positivity based on a threshold criteria of Mean Fluorescence Intensity (MFI) approaching 1000. IA will be considered present or absent using a molecular assay.
Baseline
Secondary Outcomes (1)
Incidence of HLA-DQ DSA [ Time Frame: assessed at days 3,7,15,30 post transplantation
baseline
Study Arms (2)
cases
HLA-DQ mismatched recipient-donor pairs
control
HLA-DQ matched recipient- donor pairs
Interventions
HLA typing (DQ) for donor and recipient using Luminex microbead method from EDTA blood sample
Eligibility Criteria
The study will be carried out on (30) renal transplant Recipient- Donor pairs who will be recruited from transplantation unit.
You may qualify if:
- The patients who will receive renal transplants.
You may not qualify if:
- Recipients with pre-transplantation desensitization protocols.
- Recipients with history of previous transplant or pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut U
Asyut, Egypt
Related Links
- Clinical issues in renal transplantation in the elderly. Clin Transplant 2015; 29: 167-175
- The association between broad antigen HLA mismatches, eplet HLA mismatches and acute rejection after kidney transplantation. Transplant Direct 2: e120, 20
- donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. Kidney Int 82: 598-604, 2012 .
Study Officials
- STUDY DIRECTOR
sohair k sayed, prof.doctor
clinical pathology
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
March 26, 2019
First Posted
April 1, 2019
Study Start
May 5, 2019
Primary Completion
May 5, 2020
Study Completion
May 12, 2020
Last Updated
May 19, 2020
Record last verified: 2020-05